| Literature DB >> 29724060 |
Wenjing Wang1, Xiao Wan2, Junjun Liu3, Jianping Wang4, Hucheng Zhu5, Chunmei Chen6, Yonghui Zhang7.
Abstract
A new sesquiterpenoid 9,10-diolhinokiic acid (1) and a new diterpenoid roussoellol C (2), together with 4 known compounds, were isolated from the extracts of laboratory cultures of marine-derived fungus Talaromyces purpurogenus. 9,10-diolhinokiic acid is the first thujopsene-type sesquiterpenoid containing a 9,10-diol moiety, and roussoellol C possesses a novel tetracyclic fusicoccane framework with an unexpected hydroxyl at C-4. These new structures were confirmed by spectroscopic data, chemical method, NMR data calculations and electronic circular dichroism (ECD) calculations. The selected compounds were evaluated for cytotoxicities against five human cancer cell lines, including SW480, HL-60, A549, MCF-7, and SMMC-7721 and the IC50 values of compound 2 against MCF-7 and 3 against HL-60 cells were 6.5 and 7.9 μM, respectively.Entities:
Keywords: ECD calculations; NMR data calculations; Talaromyces purpurogenus; cytotoxicities; diterpenoid; sesquiterpenoid
Mesh:
Substances:
Year: 2018 PMID: 29724060 PMCID: PMC5983281 DOI: 10.3390/md16050150
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1The structures of compounds 1–6.
1H (400 MHz) and 13C NMR (100 MHz) Data for Compound 1 and 2 (CD3OD) and DFT Calculation of 13C NMR for 2a and 2b.
| Position | 1 | 2 | 2a | 2b | ||||
|---|---|---|---|---|---|---|---|---|
|
|
| |||||||
| 1 | - | 35.7 | 1.60, d, 13.0 1.40, dd, 14.6, 13.0 | 37.6 | 39.2 | 35.9 | 36.2 | 33.7 |
| 2 | 0.85, dd, 9.1,5.0 | 11.3 | 2.70, m | 41.2 | 45.7 | 42.1 | 38.6 | 36.0 |
| 0.76, d, 5.1 | ||||||||
| 3 | 2.11, dd, 9.0, 5.1 | 17.9 | 2.45, m | 40.8 | 49.6 | 45.9 | 58.7 | 55.1 |
| 4 | - | 134.3 | 3.81, d, 4.4 | 80.0 | 86.0 | 80.7 | 85.4 | 80.6 |
| 5 | 6.56, d, 4.6 | 133.7 | - | 114.1 | 118.4 | 111.7 | 115.2 | 109.0 |
| 6 | 1.88, dd, 18.3, 2.6 | 42.8 | 3.42, br d, 9.4 | 52.8 | 57.9 | 53.8 | 55.4 | 52.0 |
| 1.78, dd, 18.3, 7.0 | ||||||||
| 7 | - | 31.9 | - | 130.5 | 133.5 | 126.2 | 133.7 | 126.7 |
| 8 | 1.57, dd, 14.4, 3.1 | 41.5 | 7.04, m | 141.6 | 156.4 | 148.1 | 148.6 | 140.9 |
| 1.50, dd, 14.4, 3.7 | ||||||||
| 9 | 4.03, ddd, 3.8, 3.7, 3.1 | 72.8 | 2.65, overlap 2.36, m | 28.6 | 31.4 | 28.5 | 31.0 | 28.7 |
| 10 | 3.23, d, 3.8 | 78.6 | 3.19, dd, 13.6, 2.8 | 47.9 | 51.9 | 48.1 | 50.0 | 46.8 |
| 11 | - | 39.9 | - | 46.9 | 53.2 | 49.3 | 51.6 | 48.3 |
| 12 | - | 171.2 | 2.28, dd, 15.1, 4.2 1.76, dd, 15.1, 2.6 | 45.5 | 46.6 | 43.0 | 48.2 | 45.9 |
| 13 | 1.44, s | 30.6 | 5.31, br s | 122.1 | 128.4 | 121.3 | 127.8 | 121.0 |
| 14 | 0.78, s | 25.9 | - | 148.4 | 159.3 | 150.9 | 159.3 | 151.1 |
| 15 | 1.31, s | 23.5 | 2.22, ddq, 7.9, 5.3, 7.4 | 36.7 | 41.6 | 38.2 | 40.8 | 38.1 |
| 16 | 0.93, d, 7.4 | 11.0 | 15.0 | 12.8 | 17.0 | 15.4 | ||
| 17 | - | 173.0 | 178.6 | 169.4 | 184.9 | 175.5 | ||
| 18 | 0.84, s | 24.9 | 25.0 | 22.4 | 25.0 | 23.0 | ||
| 19 | 1.04, d, 6.8 | 17.7 | 17.7 | 15.4 | 17.5 | 15.8 | ||
| 20 | 3.66, dd, 10.6, 5.3 3.37, dd, 10.6, 7.9 | 67.0 | 68.9 | 64.4 | 69.6 | 65.5 | ||
Figure 2Key 2D correlations of compounds 1 and 2.
Figure 3Conformation of the Mo24+ complex of compound 1 and its IECD spectrum in DMSO.
Figure 4Structures and differences in ppm between calculated and experimental 13C NMR shifts for 2a and 2b.
Figure 5Experimental and calculated ECD spectra of 2.
Cytotoxicities against Tumor Cells for 1–3 (IC50, μM).
| 1 | 2 | 3 | Adriamycin | |
|---|---|---|---|---|
| SW480 | >40 | 23.6 | 14.2 | 1.2 |
| HL-60 | 12.6 | 10.9 | 7.9 | 0.05 |
| A549 | 35.7 | 25.8 | 21.3 | 0.10 |
| MCF-7 | >40 | 6.5 | 23.8 | 0.80 |
| SMMC-7721 | >40 | >40 | >40 | 0.2 |